A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia

Authors:
  • KKKenneth J Kopecky
    Kenneth J Kopecky
  • DHDavid R Head
    David R Head
  • MGMichael R Grever
    Michael R Grever
  • HHHarry E Hynes
    Harry E Hynes
  • EKEric H Kraut
    Eric H Kraut
  • RVRichard H Vial
    Richard H Vial
  • ALAlan Lichtin
    Alan Lichtin
  • SNSucha Nand
    Sucha Nand
  • FAFrederick R Appelbaum
    Frederick R Appelbaum

Abstract
No abstract available

This publication has 10 references indexed in Scilit: